These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23278877)

  • 21. Mechanisms of sublingual immunotherapy.
    Scadding G; Durham S
    J Asthma; 2009 May; 46(4):322-34. PubMed ID: 19484663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergic rhinitis.
    Kemp AS
    Paediatr Respir Rev; 2009 Jun; 10(2):63-8. PubMed ID: 19410204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma?
    Jacobsen L; Valovirta E
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):556-60. PubMed ID: 17989534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current concepts and therapeutic strategies for allergic rhinitis in school-age children.
    Blaiss M
    Clin Ther; 2004 Nov; 26(11):1876-89. PubMed ID: 15639699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of long-term sublingual-oral immunotherapy in allergic rhinitis.
    Cingi C; Aynaci S; Cakli H; Cingi E; Ozüdogru E; Keçik C; Altin F; Bal C
    Acta Otorhinolaryngol Ital; 2005 Aug; 25(4):214-9. PubMed ID: 16482978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injection and sublingual immunotherapy in the management of allergies affecting the unified airway.
    Leatherman B
    Otolaryngol Clin North Am; 2008 Apr; 41(2):359-74, vii. PubMed ID: 18328374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.
    de Bot CM; Moed H; Berger MY; Röder E; de Groot H; de Jongste JC; van Wijk RG; van der Wouden JC
    BMC Fam Pract; 2008 Oct; 9():59. PubMed ID: 18937864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes and adverse effect monitoring in allergic rhinitis.
    Juniper EF; Ståhl E; Doty RL; Simons FE; Allen DB; Howarth PH
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S390-413. PubMed ID: 15746880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
    Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
    Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
    Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging treatments for allergic rhinitis.
    Andersson M
    Expert Opin Emerg Drugs; 2003 May; 8(1):63-9. PubMed ID: 14610912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction.
    Marple BF; Fornadley JA; Patel AA; Fineman SM; Fromer L; Krouse JH; Lanier BQ; Penna P;
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6 Suppl):S107-24. PubMed ID: 17512862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergies in India: a study on medication compliance.
    Shaikh WA; Shaikh SW
    J Indian Med Assoc; 2009 Jul; 107(7):462-3. PubMed ID: 20112853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of allergic rhinitis.
    Smith LJ
    Nurse Pract; 1995 Oct; 20(10):58-60, 62, 65-66. PubMed ID: 8532225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical efficacy of subcutaneous and sublingual immunotherapy in mite-sensitized patients with allergic rhinitis].
    Zhu L; Zhu LP; Chen RX; Tao QL; Lu JH; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):986-91. PubMed ID: 22336009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life.
    Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI
    Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Compliance and safety evaluation of subcutaneous versus sublingual immunotherapy in mite-sensitized patients with allergic rhinitis].
    Zhu L; Lu JH; Xie Q; Wu YL; Zhu LP; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jun; 45(6):444-9. PubMed ID: 21055319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved strategies and new treatment options for allergic rhinitis.
    Willsie SK
    J Am Osteopath Assoc; 2002 Jun; 102(6 Suppl 2):S7-14. PubMed ID: 12090644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.